Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mesut Yilmaz

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Journal of Clinical Medicine|July 15, 2026
Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter StudySuheda Atas Ipek, Sendag Yaslikaya, Ismail Oguz Kara, et al.
Heliyon|July 31, 2024
Factors affecting mortality in COVID-19-associated pulmonary aspergillosis: An international ID-IRI studyMeyha Sahin, Mesut Yilmaz, Ali Mert, et al.
Anti-Cancer Drugs|June 15, 2022
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group studyÖzlem Özdemir, Baha Zengel, Yaşar Yildiz, et al.
Journal of Chemotherapy (Florence, Italy)|March 18, 2024
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) studyHasan Cagri Yildirim, Caner Kapar, Baris Koksal, et al.
The Journal of Antimicrobial Chemotherapy|May 13, 2026
Emulating a target trial of early compared with late initiation of appropriate antibiotic therapy for hospital-acquired monobacterial Gram-negative bloodstream infectionsAbdullah T Aslan, Yukiko Ezure, Elif Seren Tanriverdi, et al.
International Journal of Antimicrobial Agents|July 9, 2023
Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID-IRI studyHakan Erdem, Esra Kocoglu, Handan Ankarali, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Journal of Clinical Medicine|July 15, 2026
Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter StudySuheda Atas Ipek, Sendag Yaslikaya, Ismail Oguz Kara, et al.
Heliyon|July 31, 2024
Factors affecting mortality in COVID-19-associated pulmonary aspergillosis: An international ID-IRI studyMeyha Sahin, Mesut Yilmaz, Ali Mert, et al.
Anti-Cancer Drugs|June 15, 2022
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group studyÖzlem Özdemir, Baha Zengel, Yaşar Yildiz, et al.
Journal of Chemotherapy (Florence, Italy)|March 18, 2024
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) studyHasan Cagri Yildirim, Caner Kapar, Baris Koksal, et al.
The Journal of Antimicrobial Chemotherapy|May 13, 2026
Emulating a target trial of early compared with late initiation of appropriate antibiotic therapy for hospital-acquired monobacterial Gram-negative bloodstream infectionsAbdullah T Aslan, Yukiko Ezure, Elif Seren Tanriverdi, et al.
International Journal of Antimicrobial Agents|July 9, 2023
Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID-IRI studyHakan Erdem, Esra Kocoglu, Handan Ankarali, et al.
Pageof 12